ITP Australia and New Zealand
Oct 14, 2026, 16:27
ITP Research and the Importance of Patient Involvement – ITP Australia and New Zealand
ITP Australia and New Zealand shared a post on LinkedIn:
“Every treatment available today started as a clinical trial.
Yet clinical trials remain one of healthcare’s most misunderstood aspects.
For patients, they represent:
- hope
- uncertainty
- possibility
- questions
For healthcare, they represent progress.
As the ITP treatment landscape evolves, continued patient participation in clinical research remains critical.
What do you believe is the biggest barrier preventing patients from considering clinical trial participation?
Learn more.
Check out the latest Clinical Trials.”
Stay updated with Hemostasis Today.
-
Oct 14, 2026, 16:50Peter Kouides: The Role of Multidisciplinary Networks in Women’s Hematologic Care
-
Oct 14, 2026, 16:35Thaís Leonel: Analytical Consistency as a Foundation for Evidence-Based Thrombosis Management
-
Oct 14, 2026, 16:28Christina Yiangou: Presenting the HemaFAIR Project at ASCAT 2026 in London
-
Oct 14, 2026, 16:19Ganesh Mohan: Complexities of Thrombosis Care Across Diverse Patient Populations
-
Oct 14, 2026, 16:17Louise St. Germain Bannon: Every Conversation Matters Beyond World Thrombosis Day
-
Oct 14, 2026, 16:11Christina Pierre: A Life-Course Approach to Thrombosis Risk in Women
-
Oct 14, 2026, 16:06Belinda Minnaar: Recognizing Leadership in VTE Prevention on World Thrombosis Day
-
Oct 14, 2026, 14:17Abdul Muqtadir Abbasi: PNH Treatment – Simplified for Medical Students
-
Oct 14, 2026, 14:07Barbara Adams Krolak: Highlighting Women’s Unique Risks for Blood Clots